- Medicines and Healthcare products Regulatory Agency
- 4 September 2013
- Last updated:
- 15 October 2013, see all updates
We are analysing your feedback
Visit this page again soon to download the outcome to this public feedback.
The MHRA is seeking views on the proposal on the introduction of tell-and-do variations for a specific subset of parallel import licences.
This consultation ran from
The MHRA is seeking views on the proposal on the introduction of tell-and-do variations for a specific subset of parallel import licenses, captured in a new Business Engagement Assessment, which is part of the ongoing cross-government Accountability for Regulator Impact (ARI) project.
Businesses and representative organisations are invited to comment on any aspect of the published draft Assessment. Responses should be sent to firstname.lastname@example.org stating the name of the proposal in the subject line. Responses will be published on the www.gov.uk website unless individual respondents ask us not to do so.
The deadline for comments is 1 Novemeber 2013 and final versions of the assessments will be published shortly thereafter.
MHRA business engagement assessment on introduction of tell-and-do variations for a specific subset of parallel import licences
Unnumbered act paper PDF, 39.3KB, 2 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
Published: 4 September 2013
Updated: 15 October 2013
- Updated document added.
- First published.